LENZ Therapeutics (LENZ) Cash from Operations (2022 - 2025)
LENZ Therapeutics (LENZ) has disclosed Cash from Operations for 4 consecutive years, with 33025000.0 as the latest value for Q4 2025.
- Quarterly Cash from Operations fell 263.79% to 33025000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 69170000.0 through Dec 2025, down 16.47% year-over-year, with the annual reading at 69170000.0 for FY2025, 16.47% down from the prior year.
- Cash from Operations for Q4 2025 was 33025000.0 at LENZ Therapeutics, down from 8588000.0 in the prior quarter.
- The five-year high for Cash from Operations was 8588000.0 in Q3 2025, with the low at 33025000.0 in Q4 2025.
- Average Cash from Operations over 4 years is 17641461.54, with a median of 16049000.0 recorded in 2025.
- The sharpest move saw Cash from Operations soared 39.75% in 2023, then tumbled 263.79% in 2025.
- Over 4 years, Cash from Operations stood at 22429000.0 in 2022, then skyrocketed by 42.94% to 12798000.0 in 2023, then increased by 29.07% to 9078000.0 in 2024, then crashed by 263.79% to 33025000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods came in at 33025000.0, 8588000.0, and 11508000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.